This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Youngene Therapeutics Co., Ltd.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Huijuan Zhong: A Pioneer in Therapeutic Innovations
Introduction
Huijuan Zhong is an accomplished inventor based in Jiangsu, China. With a focus on medicinal chemistry, she has made significant strides in the development of therapeutic agents. Her dedication to innovation is exemplified through her patented work, which has the potential to impact the medical field positively.
Latest Patents
Huijuan Zhong holds a patent for a C-aryl glucoside derivative, including preparation methods and medical applications. This patent describes compounds represented by formula I along with their tautomers, enantiomers, diastereomers, racemates, and pharmaceutically acceptable salts. The compounds are particularly important as they function as sodium-dependent glucose cotransporter protein (SGLT) inhibitors. Furthermore, the patent outlines methods for preparing these compounds and creating pharmaceutical compositions that leverage their therapeutic properties.
Career Highlights
Zhong currently works with Youngene Therapeutics Co., Ltd., a company known for its commitment to advancing biopharmaceutical research and therapeutic development. Her innovative approach has facilitated the creation of new treatment methodologies, positioning her as a vital player in the biopharmaceutical sector.
Collaborations
Throughout her career, Huijuan Zhong has collaborated with esteemed colleagues, including Jianchun Liao and Hongping Yu. These partnerships have fostered an environment of creative exploration, enabling the team to push boundaries in their research endeavors and bring new medical solutions to the forefront.
Conclusion
In summary, Huijuan Zhong is a trailblazer in the field of medicinal chemistry. Her patent for C-aryl glucoside derivatives not only showcases her innovative spirit but also underscores her contributions to developing effective therapeutic agents. Her work at Youngene Therapeutics Co., Ltd. and collaboration with notable peers further elevate her status as a prominent inventor in the landscape of modern medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile